作者: Michael D McKee , James P Waddell , Patricia A Kudo , Emil H Schemitsch , Robin R Richards
DOI:
关键词:
摘要: Osteonecrosis has long been recognized as a complication of systemic steroid use and was initially believed to occur only in patients who received high doses (equivalent more than 4000 mg prednisone) for extended periods (3 months or longer).[1][1],[2][2],[3][3],[4][4],[5][5],[6][6] Previous